Plato Capital Limited (SGX:YYN)

Market Cap	36.17M
Revenue (ttm)	543.74K
Net Income (ttm)	660.69K
Shares Out	12.18M
EPS (ttm)	0.05
PE Ratio	55.72
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	3,080
Open	2.970
Previous Close	2.960
Day's Range	2.970 - 2.970
52-Week Range	1.400 - 3.050
Beta	0.70
RSI	64.67
Earnings Date	Aug 11, 2025

About Theseus Pharmaceuticals

Plato Capital Limited, an investment holding company, engages in investment activities and the provision of hospitality services in Malaysia. It manages investments in quoted and unquoted equity shares, including investment in joint ventures and associates. In addition, the company provides funding and lending services. Plato Capital Limited was incorporated in 1999 and is based in Kuala Lumpur, Malaysia.

• Industry: Investors, not elsewhere classified
• Founded: 1999
• Employees: 6
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: YYN

Financial Performance

In 2024, Plato Capital's revenue was 543,740, an increase of 20.55% compared to the previous year's 451,034. Earnings were 660,689, a decrease of -94.45%.